Silexion Therapeutics Ltd. (SLXN) NASDAQ

0.91

+0.0999(+12.33%)

Updated at July 09 04:00PM

Currency In USD

Valuation

Market Cap1.25M
Enterprise Value4.56M
P/E Ratio-0.37
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio2.39
Enterprise/Revenue0
Enterprise/EBITDA-0.13

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.02
Return On Equity2.77

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-16.43M
Net Income16.51M
Diluted EPS2.03

Balance Sheet

Total Cash6.15M
Total Cash/Share0.91
Total Debt489,000
Total Debt/Equity0.19
Current Ratio3.22
Book Value Per Share0.38

Price History

52-Week Change-94.82
52-Week High13.56
52-Week Low0.21
Moving Average 50 Days0.91
Moving Average 200 Days1.09

Statistics

Average Volume1.66M
Shares Outstanding8.69M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:9
Last Split DateNovember 29, 2024